Documents / Report
This Defense Intelligence Agency reference document, dated 31 March 2010 (DIA-08-1003-020), was one of a series of advanced technology reports produced in FY 2009 under the Advanced Aerospace Weapon System Applications (AAWSA) program. It surveys biosensors and BioMEMS, covering brain-implanted neuroelectrodes, drug-delivery pumps, implantable glucose sensors, brain-machine interfaces, retinal prostheses, microfluidic lab chips, NASA cell culture systems, and microcantilever sensors. It concludes that the field is expanding rapidly toward nanomechanical systems.
UNCLASSIFIED/ /F&R: &FFHiIAL Wili &HLY have a significant problem in controlling their blood sugar and sometimes insulin doses are not adjusted finely enough or frequently enough to maintain the blood glucose at healthy levels. This form of diabetes is responsible for fainting (ketoacidosis) and other serious symptoms such as poor blood circulation to the limbs. Poor circulation can result in diabetic ulcers and may sometimes necessitate amputation of the limb. Insulin pumps are often worn by brittle diabetics because a slow infusion of insulin works better in stabilizing blood glucose levels rather than periodic injections. A belt- worn insulin-delivery system looks something like an old-style audio player. These systems are typically controlled by a small screw-type pump powered by batteries. The reservoir carries several milliliters of insulin for dispensing over an extended period of time. The injection needle is connected (underneath the clothes) to a catheter and then to the pump. The systems are reasonably effective but are cumbersome and require the needle to continuously reside subcutaneously in the abdomen. A MEMS implanted insulin pump is a less cumbersome and perhaps more convenient means of slowly infusing insulin at a programmed rate. The implanted device is refilled periodically by introducing a needle through the skin and tissue to a septum in the device. The MEMS insulin pump shown in Figure 6 is surgically placed under the skin. It has a rubber septum on the top for filling with insulin. This implementation has a piezoelectric element that moves in response to electrical charge. When actuated by a timer the element oscillates, creating a pressure inside the device that dispenses insulin. The device is programmable for dispensing at various rates. Although the implantable MEMS pump was developed for diabetes, the pump has application to the slow measured delivery of many other drugs including 5-fluoruracil used for cancer therapy and theophyllne for treatment of asthma. What is a Biosensor? A primary application of BioMEMS is in the creation of sensors for blood chemistry and other biophysical parameters of the human body. We can define a Biosensor as: • A sensor whose application is primarily in the measurement of quantities within a biological system, such as chemical, electrical, and physical parameters. • A sensor incorporating a biological component (enzymes, living cells, antibodies) typically used to measure chemical concentration. This definition does not require that the sensor be deployed within a biological system. The two definitions which are somewhat different have their origin with different influential investigators who wrote textbooks in the early days of this field. The latter definition is prevalent in Europe. A biosensor is normally constructed by immobilizing a biologically active material (such as an enzyme) onto an electrical sensor that measures a fundamental physical quantity like electrical current, voltage, mechanical strain, temperature, or frequency. The specific sensor material is chosen because it reacts to a desired measurand (such as 9 UNCLASSIFIED/ /FOR OFFICIAL USE one,
Not linked to a story yet.
Report, from the dia collection. The PDF is mirrored here; the original link is above. 45 pages are in the text index: search them above, or from the library's search.